ZA866638B - Carbapenem antibiotics - Google Patents

Carbapenem antibiotics

Info

Publication number
ZA866638B
ZA866638B ZA866638A ZA866638A ZA866638B ZA 866638 B ZA866638 B ZA 866638B ZA 866638 A ZA866638 A ZA 866638A ZA 866638 A ZA866638 A ZA 866638A ZA 866638 B ZA866638 B ZA 866638B
Authority
ZA
South Africa
Prior art keywords
carbapenem antibiotics
carbapenem
antibiotics
Prior art date
Application number
ZA866638A
Other languages
English (en)
Inventor
Alain Martel
Carol Bachand
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA866638B publication Critical patent/ZA866638B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA866638A 1985-09-11 1986-09-02 Carbapenem antibiotics ZA866638B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/774,628 US4665169A (en) 1985-09-11 1985-09-11 Carbapenem antibiotics

Publications (1)

Publication Number Publication Date
ZA866638B true ZA866638B (en) 1987-05-27

Family

ID=25101800

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA866638A ZA866638B (en) 1985-09-11 1986-09-02 Carbapenem antibiotics

Country Status (31)

Country Link
US (1) US4665169A (sv)
JP (1) JPS6261980A (sv)
KR (1) KR910006807B1 (sv)
CN (1) CN1015261B (sv)
AR (1) AR242577A1 (sv)
AT (1) AT396472B (sv)
AU (1) AU596990B2 (sv)
BE (1) BE905415A (sv)
CH (1) CH669381A5 (sv)
CS (1) CS259892B2 (sv)
DD (1) DD252605A1 (sv)
DE (1) DE3630857C2 (sv)
DK (1) DK433586A (sv)
ES (1) ES2002303A6 (sv)
FI (1) FI81803C (sv)
FR (1) FR2587704B1 (sv)
GB (1) GB2180238B (sv)
GR (1) GR862313B (sv)
HU (1) HU198491B (sv)
IL (1) IL79969A0 (sv)
IT (1) IT1207578B (sv)
LU (1) LU86575A1 (sv)
MY (1) MY102957A (sv)
NL (1) NL8602282A (sv)
NZ (1) NZ217519A (sv)
PT (1) PT83361B (sv)
SE (1) SE469630B (sv)
SU (1) SU1480764A3 (sv)
YU (1) YU45800B (sv)
ZA (1) ZA866638B (sv)
ZW (1) ZW16186A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209817B (en) * 1989-03-28 1994-11-28 Pfizer Process for the production of antibacterial 2-carbapenem derivatives
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
RU2714730C1 (ru) 2019-04-11 2020-02-19 Общество с ограниченной ответственностью "КС-ТЕХНОЛОГИИ" Конусная инерционная дробилка с опорным подшипником скольжения

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4235920A (en) * 1975-11-21 1980-11-25 Merck & Co., Inc. N-Alkylated derivatives of thienamycin
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
EP0010317B1 (en) * 1978-10-24 1983-12-21 Merck & Co. Inc. 6-, 1- and 2-substituted-1-carbapen-2-em-3-carboxylic acids, processes for the preparation of such compounds and pharmaceutical composition comprising such compounds
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
EP0037082B1 (en) * 1980-03-27 1985-03-20 Merck & Co. Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
US4309346A (en) * 1980-03-27 1982-01-05 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
JPS56161393A (en) * 1980-05-16 1981-12-11 Sanraku Inc Beta-lactam compound
CA1198440A (en) * 1982-04-08 1985-12-24 Choung U. Kim Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
FI832619A (fi) * 1982-07-26 1984-01-27 Sandoz Ag Fluoralkylerade karbapenemderivat
CA1269978A (en) * 1982-09-28 1990-06-05 Choung U. Kim Carbapenem antibiotics
DK140584A (da) * 1983-03-08 1984-09-09 Bristol Myers Co Fremgangsmaade til fremstilling af carbapenemderivater
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体

Also Published As

Publication number Publication date
FI863609A (fi) 1987-03-12
SE8603798D0 (sv) 1986-09-10
GB8621759D0 (en) 1986-10-15
AR242577A1 (es) 1993-04-30
ZW16186A1 (en) 1988-03-30
FR2587704A1 (fr) 1987-03-27
PT83361B (pt) 1989-05-12
CN1015261B (zh) 1992-01-01
DK433586D0 (da) 1986-09-10
YU158586A (en) 1988-02-29
KR870003110A (ko) 1987-04-15
CS656786A2 (en) 1988-03-15
AT396472B (de) 1993-09-27
SE8603798L (sv) 1987-03-12
GB2180238A (en) 1987-03-25
CN86105933A (zh) 1987-05-20
CH669381A5 (sv) 1989-03-15
FI81803C (sv) 1990-12-10
IL79969A0 (en) 1986-12-31
DE3630857C2 (de) 1994-04-07
AU6234886A (en) 1987-03-12
FR2587704B1 (fr) 1989-02-24
ES2002303A6 (es) 1988-08-01
DE3630857A1 (de) 1987-03-19
ATA245286A (de) 1993-01-15
HUT42487A (en) 1987-07-28
DK433586A (da) 1987-03-12
US4665169A (en) 1987-05-12
GR862313B (en) 1987-01-12
YU45800B (sh) 1992-07-20
FI863609A0 (fi) 1986-09-08
SE469630B (sv) 1993-08-09
BE905415A (fr) 1987-03-10
DD252605A1 (de) 1987-12-23
MY102957A (en) 1993-03-31
KR910006807B1 (ko) 1991-09-02
GB2180238B (en) 1989-09-06
NL8602282A (nl) 1987-04-01
FI81803B (fi) 1990-08-31
AU596990B2 (en) 1990-05-24
LU86575A1 (fr) 1987-04-02
JPS6261980A (ja) 1987-03-18
IT1207578B (it) 1989-05-25
IT8621666A0 (it) 1986-09-10
HU198491B (en) 1989-10-30
SU1480764A3 (ru) 1989-05-15
CS259892B2 (en) 1988-11-15
NZ217519A (en) 1990-07-26
PT83361A (en) 1986-10-01

Similar Documents

Publication Publication Date Title
PH22882A (en) Novel b-lactam antibiotics
ZA862987B (en) Carbapenem antibiotics
GB2163745B (en) Penam antibiotics
CY1676A (en) Antibiotics
GB2183237B (en) Carbapenem antibiotics
ZA859713B (en) B-lactam antibiotics
GB2180238B (en) Carbapenem antibiotics
AR245126A1 (es) Un procedimiento para preparar antibioticos de 1-carbacefalosporinas y compuestos intermedios de aplicacion exclusiva en dicho procedimiento .
ZA857581B (en) Carbapenem antibiotics
GB8518124D0 (en) Cephalosporin antibiotics
GB8627404D0 (en) Cephalosporin antibiotics
GB8629677D0 (en) Cephalosporin antibiotics
GB8526901D0 (en) Cephalosporin antibiotics
GB8526900D0 (en) Cephalosporin antibiotics
IE862418L (en) Carbapenem antibiotics
GB8510628D0 (en) Antibiotics
IE853252L (en) Beta-lactam antibiotics
IE850002L (en) Cephalosporin antibiotics
IE851622L (en) Cephalosporin antibiotics
GB8525988D0 (en) Cephalosporin antibiotics
GB8521975D0 (en) Cephalosporin antibiotics
IE851148L (en) Cephalosporin antibiotics
IE852247L (en) Novel antibiotics
ZA86395B (en) Novel beta-lactam antibiotics
IE850687L (en) Antibiotic tan-588